Peter Day
CMC Program Leader at Denali
- Role
- Portfolio Leader at Genentech
- Location
- San Francisco, CA, US
- LinkedIn followers
- 500 followers
About Peter Day
Director leading group responsible for developing and validating biological methods to support GMP clinical lot-release/stability and process development, product characterization for large molecules, mAbs and ADCs.Member of expert team that provides technical development guidance to early and late stage research teams. Also, led cross functional developability group responsible for assessment of all large molecules.Expertise in -Binding assays -Cell proliferation assays-Cell cytotoxicity assays-Cell Signaling assays-Strong understanding of GMP compliance, Genentech quality policies and systems and the applicable regulatory requirements.
Experience
Portfolio Leader
Oct 2022 — Present · South San Francisco, CA, US
Education
Jefferson Health
PhD
1997 — 2004
Skills
- Immunohistochemistry
- Cell Signaling
- Drug Development
- Molecular Biology
- Cell Culture
- Assay Development
- Protein Chemistry
- Cell
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.